BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 20476950)

  • 1. The metabolic syndrome and adipocytokines.
    Matsuzawa Y
    Expert Rev Clin Immunol; 2007 Jan; 3(1):39-46. PubMed ID: 20476950
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The metabolic syndrome and adipocytokines.
    Matsuzawa Y
    FEBS Lett; 2006 May; 580(12):2917-21. PubMed ID: 16674947
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapy Insight: adipocytokines in metabolic syndrome and related cardiovascular disease.
    Matsuzawa Y
    Nat Clin Pract Cardiovasc Med; 2006 Jan; 3(1):35-42. PubMed ID: 16391616
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adipocytokines and metabolic syndrome.
    Matsuzawa Y
    Semin Vasc Med; 2005 Feb; 5(1):34-9. PubMed ID: 15968578
    [TBL] [Abstract][Full Text] [Related]  

  • 5. White adipose tissue and cardiovascular disease.
    Matsuzawa Y
    Best Pract Res Clin Endocrinol Metab; 2005 Dec; 19(4):637-47. PubMed ID: 16311222
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adiponectin: a key adipocytokine in metabolic syndrome.
    Okamoto Y; Kihara S; Funahashi T; Matsuzawa Y; Libby P
    Clin Sci (Lond); 2006 Mar; 110(3):267-78. PubMed ID: 16464169
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adiponectin and metabolic syndrome.
    Matsuzawa Y; Funahashi T; Kihara S; Shimomura I
    Arterioscler Thromb Vasc Biol; 2004 Jan; 24(1):29-33. PubMed ID: 14551151
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The effects of visceral fat accumulation by diabetes mellitus on bone metabolism].
    Oshima K; Shimomura I; Iwahashi H
    Clin Calcium; 2006 Aug; 16(8):1332-42. PubMed ID: 16883042
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic syndrome: clinical concept and molecular basis.
    Funahashi T; Matsuzawa Y
    Ann Med; 2007; 39(7):482-94. PubMed ID: 17852038
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adiponectin: linking the metabolic syndrome to its cardiovascular consequences.
    Rabin KR; Kamari Y; Avni I; Grossman E; Sharabi Y
    Expert Rev Cardiovasc Ther; 2005 May; 3(3):465-71. PubMed ID: 15889974
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adipocytokines - novel link between inflammation and vascular function?
    Guzik TJ; Mangalat D; Korbut R
    J Physiol Pharmacol; 2006 Dec; 57(4):505-28. PubMed ID: 17229978
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Markers of pro-inflammatory and pro-thrombotic state in the diagnosis of metabolic syndrome.
    Odrowaz-Sypniewska G
    Adv Med Sci; 2007; 52():246-50. PubMed ID: 18217426
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of adiponectin and PBEF/visfatin as regulators of inflammation: involvement in obesity-associated diseases.
    Tilg H; Moschen AR
    Clin Sci (Lond); 2008 Feb; 114(4):275-88. PubMed ID: 18194136
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adipocytokines: emerging therapeutic targets.
    Matsuzawa Y
    Curr Atheroscler Rep; 2005 Feb; 7(1):58-62. PubMed ID: 15683604
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Adipocytokines as mediators of metabolic role of adipose tissue].
    Pandzić Jaksić V
    Acta Med Croatica; 2010 Oct; 64(4):253-62. PubMed ID: 21688608
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adipokines in diabetes and cardiovascular diseases.
    Kralisch S; Sommer G; Deckert CM; Linke A; Bluher M; Stumvoll M; Fasshauer M
    Minerva Endocrinol; 2007 Sep; 32(3):161-71. PubMed ID: 17912155
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of PPAR-alpha and -gamma agonist on the expression of visfatin, adiponectin, and TNF-alpha in visceral fat of OLETF rats.
    Choi KC; Ryu OH; Lee KW; Kim HY; Seo JA; Kim SG; Kim NH; Choi DS; Baik SH; Choi KM
    Biochem Biophys Res Commun; 2005 Oct; 336(3):747-53. PubMed ID: 16157299
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The metabolic syndrome: metabolic changes with vascular consequences.
    Wassink AM; Olijhoek JK; Visseren FL
    Eur J Clin Invest; 2007 Jan; 37(1):8-17. PubMed ID: 17181562
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dietary regulation of nuclear receptors in obesity-related metabolic syndrome.
    Kawada T; Goto T; Hirai S; Kang MS; Uemura T; Yu R; Takahashi N
    Asia Pac J Clin Nutr; 2008; 17 Suppl 1():126-30. PubMed ID: 18296319
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of fat topology in the risk of disease.
    Matsuzawa Y
    Int J Obes (Lond); 2008 Dec; 32 Suppl 7():S83-92. PubMed ID: 19136997
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.